Related content

ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 33, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. : 43-53

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphisms of CYP2C19 and CYP2D6 in Israeli Ethnic Groups

By Huai-Rong Luo  

American Journal of PharmacoGenomics, Vol. 4, Iss. 6, 2004-01 ,pp. : 395-401

Adis International

Access to resources Recommend Favorite

Influence of CYP2C9 and CYP2D6 Polymorphisms on the Pharmacokinetics of Nateglinide in Genotyped Healthy Volunteers

By Kirchheiner J.  

Clinical Pharmacokinetics, Vol. 43, Iss. 4, 2004-01 ,pp. : 267-278

Adis International

Access to resources Recommend Favorite

Allele Frequencies of CYP2D6, CYP3A5 and DPYD Genes Polymorphisms in the Healthy Yakut Population

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 1, 2017-01 ,pp. : 50-55

Bentham Science Publishers

Access to resources Recommend Favorite